2019
DOI: 10.1111/bdi.12835
|View full text |Cite
|
Sign up to set email alerts
|

Is RDoC our Doc? The clinical translation of scientific inquiry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
9
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(9 citation statements)
references
References 4 publications
0
9
0
Order By: Relevance
“…The MDcpg 2020 recognises practical strengths of these taxonomies such as their reliability, familiarity and frequency of uptake and therefore they remain an option for describing the clinical presentations of mood disorders. However, there are key aspects (see 1–3 below) that we consider to be important for achieving more accurate and meaningful diagnoses (Malhi and Bell, 2019c). In addition, the MDcpg 2020 provides alternative schemas that better approximate clinical description with reality and enrich diagnostic formulation:…”
Section: Classificationmentioning
confidence: 99%
“…The MDcpg 2020 recognises practical strengths of these taxonomies such as their reliability, familiarity and frequency of uptake and therefore they remain an option for describing the clinical presentations of mood disorders. However, there are key aspects (see 1–3 below) that we consider to be important for achieving more accurate and meaningful diagnoses (Malhi and Bell, 2019c). In addition, the MDcpg 2020 provides alternative schemas that better approximate clinical description with reality and enrich diagnostic formulation:…”
Section: Classificationmentioning
confidence: 99%
“…One of the major clinical problems is that our current taxonomy lacks specificity and fails to define clear boundaries of the disorder. Hence, significant effort has been invested to define BD across domains beyond its clinical symptoms, such as cognitive and behavioural functioning, neurophysiology, neural circuitry, at a molecular level and using genetic markers 5 . But thus far we still have a heterogeneous syndrome that is largely defined on the basis of clinical signs and symptoms.…”
Section: A Cautionary Note …mentioning
confidence: 99%
“…The substantial heterogeneity and comorbidity associated with the current definition of BD renders it impossible to determine the true nature of the illness, and thus we are unable to test the underlying assumptions of staging ‐ such as neuroprogression and the illness following a predictable trajectory. To this day, researchers and clinicians alike, struggle to accurately classify a bipolar illness and vigorous debate regarding diagnostic classification (i.e., DSM/ICD vs RDoC) continues 5 . Therefore, it is necessary that we first focus our efforts on identifying a well‐defined, homogenous group, based on clinical symptomology by excluding all comorbidities and compounding variables (e.g., psychological and physical comorbidities, age, culture, and ethnicity).…”
Section: Recommendationsmentioning
confidence: 99%
“…In the commentary on the tension between the research Domain Criteria (RDoC) from NIMH and the DSM categories of psychiatric disorders, Gin Malhi discusses the origin, structure, and rationale for RDoC . The RDoC domains include negative valence, positive valence, cognitive systems, systems for social processes, and arousal/modulatory systems.…”
mentioning
confidence: 99%
“…
In the commentary on the tension between the research Domain Criteria (RDoC) from NIMH and the DSM categories of psychiatric disorders, Gin Malhi discusses the origin, structure, and rationale for RDoC. 1 The RDoC domains include negative valence, positive valence, cognitive systems, systems for social processes, and arousal/ modulatory systems. He includes a rather impressive RDoC schematic of the hierarchical levels of increasing complexity from genes, to molecules to circuits to physiology to behavior and then self-report derived DSM diagnoses.
…”
mentioning
confidence: 99%